Published in J Immunol on December 01, 2004
Induction of B-cell immune tolerance by antigen-modified cytotoxic T lymphocytes. Transplantation (2010) 1.43
Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway. Blood (2008) 0.95
CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood (2010) 0.87
Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells. Blood (2009) 0.85
Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection. Biol Blood Marrow Transplant (2006) 0.78
The use of donor-derived veto cells in hematopoietic stem cell transplantation. Front Immunol (2012) 0.78
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood (2011) 4.57
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol (2005) 3.81
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Hsp90 recognizes a common surface on client kinases. J Biol Chem (2006) 2.12
Human and porcine early kidney precursors as a new source for transplantation. Nat Med (2002) 1.73
Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol (2006) 1.59
Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation. EMBO Rep (2004) 1.46
Reconstruction of cell lineage trees in mice. PLoS One (2008) 1.46
Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res (2006) 1.39
Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A (2009) 1.32
Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells (2009) 1.25
Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows. Proc Natl Acad Sci U S A (2005) 1.19
Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. PLoS Med (2006) 1.14
Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells (2006) 1.11
Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin. Exp Hematol (2006) 1.11
Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse. J Biol Chem (2008) 1.09
Estimating cell depth from somatic mutations. PLoS Comput Biol (2008) 1.06
"Designed" grafts for HLA-haploidentical stem cell transplantation. Blood (2013) 1.03
Wishbone identifies bifurcating developmental trajectories from single-cell data. Nat Biotechnol (2016) 1.02
Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7. Blood (2012) 0.99
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. Best Pract Res Clin Haematol (2011) 0.97
Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation. Proc Natl Acad Sci U S A (2006) 0.94
Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells. Exp Hematol (2006) 0.93
Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol (2002) 0.93
A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood (2013) 0.91
Embryonic porcine liver as a source for transplantation: advantage of intact liver implants over isolated hepatoblasts in overcoming homeostatic inhibition by the quiescent host liver. Stem Cells (2008) 0.90
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood (2002) 0.90
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. J Immunol (2004) 0.90
The haploidentical option for high-risk haematological malignancies. Blood Cells Mol Dis (2007) 0.90
CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood (2010) 0.87
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha. Blood (2004) 0.87
Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells. Blood (2009) 0.85
Transplants across human leukocyte antigen barriers. Semin Hematol (2002) 0.85
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells. Ann N Y Acad Sci (2003) 0.84
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood (2003) 0.84
Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells. J Immunol (2007) 0.84
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells. Ann N Y Acad Sci (2005) 0.83
Induction of tolerance in organ recipients by hematopoietic stem cell transplantation. Int Immunopharmacol (2009) 0.82
Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol Cancer Ther (2005) 0.82
Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004. Blood Cells Mol Dis (2004) 0.80
Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs. Blood (2004) 0.80
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. Blood Cells Mol Dis (2004) 0.80
Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis. Biol Blood Marrow Transplant (2007) 0.80
Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells. Transplantation (2011) 0.79
TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement. J Immunol (2011) 0.79
Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras. J Clin Immunol (2003) 0.79
Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation. Transplantation (2010) 0.78
The use of donor-derived veto cells in hematopoietic stem cell transplantation. Front Immunol (2012) 0.78
Embryonic committed stem cells as a solution to kidney donor shortage. Expert Opin Biol Ther (2004) 0.78
Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells. J Hematother Stem Cell Res (2002) 0.77
Engraftment of human early kidney precursors. Transpl Immunol (2004) 0.77
Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation. Immunol Allergy Clin North Am (2010) 0.77
Growth enhancement by embryonic fibroblasts upon cotransplantation of noncommitted pig embryonic tissues with fully committed organs. Transplantation (2010) 0.77
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up. Am J Hematol (2012) 0.77
A novel small animal model for HIV-1 infection. FASEB J (2005) 0.77
Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation. Hematol Oncol Clin North Am (2011) 0.77
Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance. Regen Med (2015) 0.76
Megadose stem cell administration as a route to mixed chimerism. Curr Opin Organ Transplant (2014) 0.76
A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells. Blood (2013) 0.76
Fetal pancreas as a source for islet transplantation: sweet promise and current challenges. Diabetes (2013) 0.75
Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control. PLoS One (2009) 0.75
Embryonic porcine skin precursors can successfully develop into integrated skin without teratoma formation posttransplantation in nude mouse model. PLoS One (2010) 0.75
Large-scale generation of human allodepleted anti-3rd party lymphocytes. Blood Cells Mol Dis (2007) 0.75
Nathan Sharon: 1925-2011. Adv Carbohydr Chem Biochem (2012) 0.75
Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype. Best Pract Res Clin Haematol (2011) 0.75
T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences. Elife (2017) 0.75
T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts. Transplantation (2002) 0.75
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. Hum Immunol (2005) 0.75
Crossing the HLA barriers. Blood Cells Mol Dis (2004) 0.75